Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now includes an NIH grant/contract annotation for 2018. The page revision has been updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedSponsor and collaborators information, along with expanded MeSH terms and keywords, have been added to the study record to improve attribution and searchability. The changes also incorporate references like Plan for IPD and related terminology to better describe the study and its context.SummaryDifference69%

- Check37 days agoChange DetectedThe page revision has been updated to v3.6.5, replacing v3.6.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check44 days agoChange DetectedNo changes were recorded in the provided data; the page content remains as previously captured.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4. This reflects a small refresh of the page without changes to the study data.SummaryDifference0.1%

- Check65 days agoChange DetectedNo textual changes were reported for the page; the content remains the same as the previous version.SummaryDifference0.1%

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.